AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO) today announced the pricing of its previously announced underwritten public offering of 21,739,131 shares of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

AVEO Pharmaceuticals, Inc. Announces Pricing of $25 Million Underwritten Public OfferingApril 3, 2019 11:35 PM After-Hours Movers 04/03: (REPH) (TST) (CBLK) Higher; (NSPR) (AVEO) (SGMO) (more...)April 3, 2019 5:23 PM AVEO Oncology (AVEO) to Offer Common StockApril 3, 2019 4:01 PM Pre-Open Stock Movers 04/03: (APRN) (I) (PLAY) Higher; (FSNN) (AVEO) (GME) Lower (more...)April 3, 2019 9:20 AM AVEO Oncology (AVEO) discloses CHMP regulatory action may be considered if August 2019 interim OS analysis confirms negative trendApril 3, 2019 6:46 AM Pre-Open Stock Movers 04/02: (ADMA) (SGMO) (RIOT) Higher; (APYX) (EFOI) (WBA) Lower (more...)April 2, 2019 9:24 AM